Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067369152> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2067369152 endingPage "720" @default.
- W2067369152 startingPage "715" @default.
- W2067369152 abstract "Article AbstractBackground: Body dysmorphic disorder (BDD), a preoccupation with an imagined or slight defect in appearance, is a relatively common and impairing disorder. While available data suggest that serotonin reuptake inhibitors are effective for BDD, investigation of this disorder's response to pharmacotherapy is limited, and there are no published reports on the efficacy of the selective serotonin reuptake inhibitor citalopram. In addition, there are no published reports on change in quality of life and multiple domains of psychosocial functioning with pharmacologic treatment for patients with BDD. Method: Fifteen subjects with DSM-IV BDD or its delusional variant were prospectively treated in a 12-week open-label trial of citalopram. Subjects were assessed at regular intervals with the Yale-Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS; the primary outcome measure), the Clinical Global Impressions scale (CGI), the Brown Assessment of Beliefs Scale, measures of quality of life and multiple domains of psychosocial functioning, and other scales. Data were collected from Dec. 28, 1999, to March 1, 2001. Results: On the BDD-YBOCS, scores decreased from a mean ± SD of 30.7 ± 4.9 at baseline to 15.3 ± 10.6 at endpoint (p < .001), and 73.3% (N = 11) of subjects were responders. On the CGI, 40.0% of patients (N = 6) were very much improved, and 26.7% (N = 4) were much improved. Psychosocial functioning and mental health-related quality of life also significantly (p < .05) improved. The mean dose of citalopram was 51.3 ± 16.9 mg/day, and the mean time to response was 4.6 ± 2.6 weeks. Citalopram was generally well tolerated. Conclusion: Citalopram appears safe and effective for BDD. Psychosocial functioning and quality of life also significantly improved with citalopram." @default.
- W2067369152 created "2016-06-24" @default.
- W2067369152 creator A5033926510 @default.
- W2067369152 creator A5068093329 @default.
- W2067369152 date "2003-06-15" @default.
- W2067369152 modified "2023-10-03" @default.
- W2067369152 title "An Open-Label Study of Citalopram in Body Dysmorphic Disorder" @default.
- W2067369152 doi "https://doi.org/10.4088/jcp.v64n0615" @default.
- W2067369152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12823088" @default.
- W2067369152 hasPublicationYear "2003" @default.
- W2067369152 type Work @default.
- W2067369152 sameAs 2067369152 @default.
- W2067369152 citedByCount "129" @default.
- W2067369152 countsByYear W20673691522012 @default.
- W2067369152 countsByYear W20673691522013 @default.
- W2067369152 countsByYear W20673691522014 @default.
- W2067369152 countsByYear W20673691522015 @default.
- W2067369152 countsByYear W20673691522016 @default.
- W2067369152 countsByYear W20673691522017 @default.
- W2067369152 countsByYear W20673691522018 @default.
- W2067369152 countsByYear W20673691522019 @default.
- W2067369152 countsByYear W20673691522020 @default.
- W2067369152 countsByYear W20673691522021 @default.
- W2067369152 countsByYear W20673691522022 @default.
- W2067369152 countsByYear W20673691522023 @default.
- W2067369152 crossrefType "journal-article" @default.
- W2067369152 hasAuthorship W2067369152A5033926510 @default.
- W2067369152 hasAuthorship W2067369152A5068093329 @default.
- W2067369152 hasConcept C118552586 @default.
- W2067369152 hasConcept C123273963 @default.
- W2067369152 hasConcept C126322002 @default.
- W2067369152 hasConcept C150966472 @default.
- W2067369152 hasConcept C15744967 @default.
- W2067369152 hasConcept C2777490545 @default.
- W2067369152 hasConcept C2778455770 @default.
- W2067369152 hasConcept C2779177272 @default.
- W2067369152 hasConcept C2779951463 @default.
- W2067369152 hasConcept C2780092697 @default.
- W2067369152 hasConcept C31487548 @default.
- W2067369152 hasConcept C542102704 @default.
- W2067369152 hasConcept C558461103 @default.
- W2067369152 hasConcept C70410870 @default.
- W2067369152 hasConcept C71924100 @default.
- W2067369152 hasConceptScore W2067369152C118552586 @default.
- W2067369152 hasConceptScore W2067369152C123273963 @default.
- W2067369152 hasConceptScore W2067369152C126322002 @default.
- W2067369152 hasConceptScore W2067369152C150966472 @default.
- W2067369152 hasConceptScore W2067369152C15744967 @default.
- W2067369152 hasConceptScore W2067369152C2777490545 @default.
- W2067369152 hasConceptScore W2067369152C2778455770 @default.
- W2067369152 hasConceptScore W2067369152C2779177272 @default.
- W2067369152 hasConceptScore W2067369152C2779951463 @default.
- W2067369152 hasConceptScore W2067369152C2780092697 @default.
- W2067369152 hasConceptScore W2067369152C31487548 @default.
- W2067369152 hasConceptScore W2067369152C542102704 @default.
- W2067369152 hasConceptScore W2067369152C558461103 @default.
- W2067369152 hasConceptScore W2067369152C70410870 @default.
- W2067369152 hasConceptScore W2067369152C71924100 @default.
- W2067369152 hasIssue "6" @default.
- W2067369152 hasLocation W20673691521 @default.
- W2067369152 hasLocation W20673691522 @default.
- W2067369152 hasOpenAccess W2067369152 @default.
- W2067369152 hasPrimaryLocation W20673691521 @default.
- W2067369152 hasRelatedWork W1608131920 @default.
- W2067369152 hasRelatedWork W2014104788 @default.
- W2067369152 hasRelatedWork W2035490907 @default.
- W2067369152 hasRelatedWork W2057689347 @default.
- W2067369152 hasRelatedWork W2067369152 @default.
- W2067369152 hasRelatedWork W2408256799 @default.
- W2067369152 hasRelatedWork W2410088886 @default.
- W2067369152 hasRelatedWork W4236621477 @default.
- W2067369152 hasRelatedWork W4247334449 @default.
- W2067369152 hasRelatedWork W4255535768 @default.
- W2067369152 hasVolume "64" @default.
- W2067369152 isParatext "false" @default.
- W2067369152 isRetracted "false" @default.
- W2067369152 magId "2067369152" @default.
- W2067369152 workType "article" @default.